Nocebo Effect

3

Review clinical trials related to Nocebo Effect. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Muscle Synergies in Pain and Pain Anticipation

This study investigates how the anticipation of pain affects muscle synergies. One group will be recruited who will first experience actual pain from capsaicin cream and are then presented with a harmless cream deceptively labeled as capsaicin. The changes in muscle synergies will be measured during walking tasks.

Participants needed: 12
Trial details
Age: 18-35Biological sex: AllType: InterventionalSponsor: Universite de Picardie Jules VerneUpdated: Jun 11, 2026Locations: 2
Eligibility criteria

Aged 18-35 years old [+3]

Presence of pain at the time of testing [+13]

Status: Recruiting

Muscular Synergies and Behavioral Adaptations of Gait in Pain Anticipation (SYAMAPP)

The purpose of this study is to determine whether the anticipation of pain influences gait control and psychophysiological responses in healthy individuals. Participants will receive a neutral cream described either as potentially painful (experimental group) or inert (control group), and their behavioral and physiological adaptations will be measured during walking tasks.

Participants needed: 34
Trial details
Age: 18-35Biological sex: AllType: InterventionalSponsor: Universite de Picardie Jules VerneUpdated: Jun 11, 2026Locations: 1
Eligibility criteria

Aged 18-35 years [+3]

Presence of pain at the time of testing [+13]

Status: Not yet recruiting

Neurophysiological Mechanisms of Placebo and Nocebo Effects in Sports - a Protocol Paper

This clinical trial aims to investigate the neurophysiological mechanisms of placebo and nocebo effects on sports performance, using Electroencephalography (EEG) and isometric strength testing of the lower extremities. The primary objective of this trial is to identify temporal mechanisms and cortical regions and networks involved in generating placebo and nocebo effects before (expectation) and at onset of athletic performance (perception). The trial will include four groups, two of them experimental, one an active control and one natural history, meaning participants in this group will receive no intervention and won't be EEG controlled. Data will be collected on two occasions with baseline data for EEG, expectations and performance as well as key participant characteristics being collected on day one. On day two, in a deceptive process, participants in the two experimental groups will take an inert substance presented as either performance enhancing or inhibiting and subsequently experience a reinforcement of beliefs via exposure to explicit adjectives. EEG data will be collected during reinforcement of beliefs. In the active control group, participants will receive no substance, but this group will follow the same procedure as the experimental groups with neutral adjectives. Participants will then perform isometric strength and fatigue resistance tests on an isometric dynamometer. EEG data as well as subjective data on expectations and rating of perceived exhaustion will be collected.

Participants needed: 56
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Canterbury Christ Church UniversityUpdated: Feb 19, 2025Locations: 1
Eligibility criteria

Healthy adult participants (18+) [+6]